Ribonucleotide reductase M1 gene promoter activity, polymorphisms, population frequencies, and clinical relevance
- 1 February 2005
- journal article
- Published by Elsevier BV in Lung Cancer
- Vol. 47 (2), 183-192
- https://doi.org/10.1016/j.lungcan.2004.07.043
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- RRM1 and PTEN As Prognostic Parameters for Overall and Disease-Free Survival in Patients With Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2004
- Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancerOncogene, 2003
- RRM1-induced metastasis suppression through PTEN-regulated pathwaysOncogene, 2003
- Prognostic Significance of Molecular Genetic Aberrations on Chromosome Segment 11p15.5 in Non-Small-Cell Lung CancerJournal of Clinical Oncology, 2002
- Ribonucleotide reductases in the twenty-first centuryProceedings of the National Academy of Sciences of the United States of America, 1998
- The R1 component of mammalian ribonucleotide reductase has malignancy-suppressing activity as demonstrated by gene transfer experimentsProceedings of the National Academy of Sciences, 1997
- Mouse ribonucleotide reductase: from genes to proteinsBiochemical Society Transactions, 1995
- Three tumor-suppressor regions on chromosome 11p identified by high-resolution deletion mapping in human non-small-cell lung cancer.Proceedings of the National Academy of Sciences of the United States of America, 1994
- Ribonucleotide reductase: regulation, regulation, regulationTrends in Biochemical Sciences, 1992
- The structural gene for the M1 subunit of ribonucleotide reductase maps to chromosome 11, band p15, in human and to chromosome 7 in mouseExperimental Cell Research, 1988